Answers are grounded in this paper and cite their sources.
Review reports persistent delays and severe underutilization of surgery in refractory temporal lobe epilepsy, highlighting the need to expand global access.
Surgical treatment for epilepsy remains highly underutilized: in the United States, there has been no increase in the number of surgical procedures performed annually since 19901; for most patients referred, the average duration of epilepsy is 22 years2; and there has been no change in this delay to surgery3, despite two randomized controlled trials4, 5 and an American Academy of Neurology practice parameter that recommended surgery as the treatment of choice for medically refractory temporal lobe epilepsy6. This session addressed issues relevant to increasing the availability of epilepsy surgery, particularly in countries with limited resources.
No takes yet. Share an insight, caveat, or question.
Jerome Engel (2008) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: